Human Chorionic Gonadotropin (HCG) Market to Witness Robust Growth in North America

 


Human chorionic gonadotropin is a naturally occurring hormone produced by the trophoblast glands surrounding an ovulating woman's developing fetus, which forms the egg cell during fertilization. The presence of human chorionic gonadotropin (HCG) is commonly detected in early pregnancy tests. The HCG levels can be determined with the help of urine or blood test. These tests are commonly used to identify and confirm pregnancy or to determine birth defects. Growth of the Human Chorionic Gonadotropin (HCG) Market is mainly driven by the increasing incidence of infertility around the world.

According to the World Health Organization (WHO), infertility affects millions of people of reproductive age worldwide. Estimates suggest that more than 186 million individuals and 48 million couples live with infertility worldwide. Thus, there is a growing demand for infertility treatments, such as HCG in order for females to conceive a child. Some women who are tested negative for HCG are then advised to take additional tests to confirm it during pregnancy. A positive result from one such test indicates that HCG may be the primary hormone secreted in the pregnant woman. Other tests include testing of serum creatinine, follicle stimulating hormone, and estrogen levels in urine.

Moreover, various other factors, such as polycystic ovary syndrome, hormonal imbalance, and endometriosis, are expected to drive the growth of the Human Chorionic Gonadotropin (HCG) Market. Polycystic ovary syndrome (PCOS) one of the most common causes of infertility. According to the Office on Women's Health (OWH), part of the U.S. Department of Health and Human Services (DHHS), PCOS affects one in ten women of childbearing age. This lifelong health condition continues far beyond the child-bearing years. Thus, there is a growing demand for infertility treatments around the world, driving the human chorionic gonadotropin (HCG) market growth.

Furthermore, the Human Chorionic Gonadotropin (HCG) Market is expected to witness robust growth in North America due to increasing number of infertility cases and increasing incidence of hormonal dysfunction among both males and females. According to the Centers for Disease Control and Prevention (CDC), around 10% of women (6.1 million) aged 15 to 44 years in the United States have difficulty getting pregnant or staying pregnant. Thus, the rapidly increasing infertility cases of are expected to increase the demand for infertility treatments. However, the availability of alternatives for the treatment of infertility could act as potential barriers for the human chorionic gonadotropin (HCG) market growth.


Comments

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027

Monochloroacetic Acid (MCAA) Market Is Estimated To Witness High Growth Owing To Increasing Demand for Surfactants and Herbicides